Sumitomo Mitsui Trust Holdings, Inc. Biomarin Pharmaceutical Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $164 Billion
- Q4 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 11,700 shares of BMRN stock, worth $640,341. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,700
Previous 451,980
97.41%
Holding current value
$640,341
Previous $24.5 Million
97.39%
% of portfolio
0.0%
Previous 0.01%
Shares
35 transactions
Others Institutions Holding BMRN
# of Institutions
657Shares Held
183MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...